Trial Profile
A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms DDD
- 01 Oct 2009 Results published in the European Journal of Heart Failure.
- 03 Sep 2008 Results presented at ESC 2008.
- 16 Jun 2008 Status changed from active, no longer recruiting to completed (source: ClinicalTrials.gov).